- Home
- REKR vs XBIT Comparison
REKR vs XBIT Comparison
Compare REKR & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- XBIT
- Stock Information
- Founded
- REKR 2017
- XBIT 2005
- Country
- REKR United States
- XBIT United States
- Employees
- REKR N/A
- XBIT N/A
- Industry
- REKR Telecommunications Equipment
- XBIT Pharmaceuticals and Biotechnology
- Sector
- REKR Telecommunications
- XBIT Health Care
- Exchange
- REKR Nasdaq
- XBIT Nasdaq
- Market Cap
- REKR 115.1M
- XBIT 105.2M
- IPO Year
- REKR N/A
- XBIT 2015
- Fundamental
- Price
- REKR $0.70
- XBIT $2.71
- Analyst Decision
- REKR
- XBIT
- Analyst Count
- REKR 0
- XBIT 0
- Target Price
- REKR N/A
- XBIT N/A
- AVG Volume (30 Days)
- REKR 3.8M
- XBIT 40.6K
- Earning Date
- REKR 05-14-2025
- XBIT 05-09-2025
- Dividend Yield
- REKR N/A
- XBIT N/A
- EPS Growth
- REKR N/A
- XBIT N/A
- EPS
- REKR N/A
- XBIT N/A
- Revenue
- REKR $46,028,000.00
- XBIT N/A
- Revenue This Year
- REKR $42.85
- XBIT N/A
- Revenue Next Year
- REKR $36.19
- XBIT N/A
- P/E Ratio
- REKR N/A
- XBIT N/A
- Revenue Growth
- REKR 31.76
- XBIT N/A
- 52 Week Low
- REKR $0.75
- XBIT $2.92
- 52 Week High
- REKR $2.67
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- REKR 29.74
- XBIT 38.75
- Support Level
- REKR $0.79
- XBIT $3.15
- Resistance Level
- REKR $0.91
- XBIT $3.31
- Average True Range (ATR)
- REKR 0.08
- XBIT 0.16
- MACD
- REKR -0.00
- XBIT -0.04
- Stochastic Oscillator
- REKR 3.41
- XBIT 0.00
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.